Printer Friendly

Adverse reactions in allogeneic blood donors: a tertiary care experience from a developing country.

Blood cannot be produced synthetically and, therefore, donation is required. The procedure is voluntary and is carried out by phlebotomists. Most blood donations are safe especially in tertiary care centers where the phlebotomists are trained and the staffare skilled and well equipped. Developing countries like Pakistan, often face blood shortages owing to lack of awareness and unmotivated community support and are mainly reliant on family/replacement donors. Replacement donors can be retained as future regular voluntary donors. However, adverse events can negatively affect donor retention and recruitment. (1) Donor retention is directly linked with donor satisfaction. An adverse reaction has a negative impact on donor's revisiting. (2)

Generally, blood donors do not experience adverse symptoms and tolerate the donation process very well, but adverse reactions of variable severity occasionally occur during or at the end of the blood collection. (3) Usually, these are minor symptoms related to the donation process. However, rarely, serious adverse symptoms may occur. These symptoms range from a mild vasovagal reaction (VVR), nausea, vomiting, and hyperventilation to hematoma, incontinence, nerve injury, arterial prick, and may culminate in delayed syncope, cardiac arrest, and seizures.

Adverse reactions have been observed in various ethnic backgrounds in 0.6-36% of cases. (4,5) From South Asia, data about adverse donor reactions is available from India and Bangladesh, but there is little data available from Pakistan. To the best of our knowledge, the single study reported looked merely for adverse VVR in healthy blood donors. (6)

The aim of our study was to assess the frequency of these adverse reactions at a tertiary care hospital in Karachi, and also to determine the entire spectrum of different adverse events. We also wanted to determine any association with age, gender, weight, race, and educational status. Thus, our study sought to identify a vulnerable donors group who are at risk of developing various adverse reactions.

METHODS

This prospective study was conducted over three years, between January 2011 to December 2013. We used the non-probability, feasibility-sampling method and recruited a total of 41,759 allogeneic blood donors. The study was approved by the ethical and research committee of Liaquat National Hospital, Karachi, Pakistan.

Demographic data obtained via a structural questionnaire included the donor's name, age, gender, contact number, donor type (replacement or voluntary), linguistic background, and educational status. All donors were selected according to preestablished inclusion criteria considering age ([greater than or equal to] 18 years), body weight (> 50 kg), hemoglobin levels ([greater than or equal to] 12.5 g/dl), hematocrit levels (HCT) [greater than or equal to] 38%, pulse (50-100 beats/min), and blood pressure (120/80 mmHg). All subjects were asked about their medical and donation history. Donors with a history of jaundice, intravenous drug abuse, non-marital sexual contact, tattoos, and recent blood transfusion or surgery were deferred and excluded from the study. All donors were interviewed and provided written informed consent.

Approximately 500 ml of whole blood was drawn by trained phlebotomists. All donors were observed for any possible adverse events during donation and were detained subsequently for 20 minutes after blood donation. All donors were asked to report back in the case of any delayed adverse events within 24 hours.

Donors were divided into groups based on their age (< 30 and [greater than or equal to] 30 years), gender, linguistic background (Urdu or non-Urdu speaking), weight (< 70, 71-90 and > 90 kg), and education (undergraduate, graduate or postgraduate). NonUrdu speaking languages included Sindhi, Pashto, Punjabi, Balochi, and Hindko.

The frequencies of different adverse reactions in blood donors were calculated. Association between blood donor adverse reactions and age, race, education, and weight was calculated using the chi-square test. A p-value < 0.050 was considered significant. The data was analyzed using SPSS Statistics (SPSS Inc., Chicago, US) version 21.

RESULTS

A total of 41,759 blood donors were enrolled over a period of three years. Of these, 41,511 (99.5%) were replacement donors and 248 (0.5%) were voluntary donors. Almost all donors (41,645; 99.8%) were male. One-hundred and fourteen (0.2%) were female. The mean age was 26.0 [+ or -] 6.8 years and their mean weight was 66.5 [+ or -] 9.4 kg. Of the total number of donors, 537 developed adverse reactions; of these, 429 (79.9%) developed VVR. Donors with VVR showed various signs and symptoms as shown in Table 1. The overall frequency of adverse donor reactions was 1.3% with an estimated incidence of one in every 78 blood donations.

The second most common adverse reaction was nausea in 133 (24.8%) donors followed by fainting (n = 63; 11.8%). Thirty-five (6.5%) donors developed hyperventilation, nine (1.7%) developed delayed syncope, and nine (1.7%) developed hematoma. Arterial prick, nerve injury, cardiac arrest, incontinence, and seizures were not recorded.

An association was seen with age, weight, linguistic background, and educational status. A significant positive association was found between age and VVR (p = 0.000). VVR were seen predominantly in the < 30 years age group. A significant association between age and nausea (p = 0.003) and hyperventilation (p = 0.000) was also seen [Table 2].

There was a significant positive association between VVR and weight (p = 0.004). Donors weighing less than 70 kg were positively associated with VVR (p = 0.004). Nausea (p = 0.017) was also significantly associated with weight. There was a positive correlation between nausea (p = 0.031) and delayed syncope (p = 0.011). Fainting (p = 0.000) and hematoma (p = 0.001) were seen more commonly in donors educated to an undergraduate level.

DISCUSSION

Blood banks have a dual responsibility: to meet the blood supply for the community and to ensure maximum blood donors safety. The donor's physical experiences have a noticeable impact on donor return, and adverse incidents dictate the donor return rate. (7) Our study revealed adverse donor reactions in 1.3% of healthy Pakistani allogeneic donors. This is the first comprehensive report from Pakistan; a prior study addressed only VVR in replacement donors. (6)

Our results are in concurrence with an Indian study that reported adverse events in 2.5% of healthy blood donors. (8) Another local study from Bangalore, India revealed a prevalence of 2.04%. (9) A relatively high prevalence of 4.9% was reported in a study from Bangladesh that assessed randomly selected whole blood donors. (10)

Compared to data from developed countries, our results are more or less analogous. An Italian study found an overall prevalence 1.2%. (11) A large study from Japan on 98,389 donors recorded a 2.8% positivity rate of adverse reactions. (12) However, a relatively low frequency of 0.63% adverse reactions was determined in a German study, conducted in elderly (66-71 years) voluntary blood donors. (4) This difference is accredited to difference in the age groups of our studies, and the blood donor type (i.e., voluntary donations versus replacement donors) as in our study included virtually all replacement donors. Regular voluntary donors are likely to have less adverse donor reaction.

VVR were the most common adverse reaction occurring in 67-95% of all donation-related reactions and in 1-5% of blood donors. (13) Donation-related VVR is a multifactorial response primarily determined by young age, low weight, female gender, and first-time donor status. (14-16)

Rohra et al, (6) conducted a study in two blood banks in Karachi, Pakistan, and reported a higher prevalence (8.2%) of VVR in 674 exchange blood donors. This difference perhaps could be explained by the majority of donors being aged < 30 years. The sample size was relatively small in their study where as our cohort was larger and is more likely to reflect the actual prevalence in our population.

However, earlier studies from India reported VVR prevalences of 63.5% and 70.0%, which are comparable to our findings of 79.9%.8'17 Age and weight might predict the VVR in blood donors, based on significant associations observed. Previous studies reported a significantly low frequency of VVR in those aged [greater than or equal to] 36 years old. (8) The highest prevalence was seen in the < 30 age group in our study. A study from France postulated that vasovagal reactors exhibited decreased baroreceptor sensitivity in healthy younger donors when they are physically or psychologically strained. (18) With escalating age, the body becomes steadier hemodynamically.

An adverse event was frequently seen in donors who weighed less than 70 kg. Previous studies support our findings. Donors who experienced adverse reactions had a lower mean weight compared to donors without adverse events. (19) Newman also showed that the VVR reaction rate was inversely proportional to the donors weight. (20) A cumulative report from three large US blood centers also revealed that low weight donors had high donation reaction (VVR) rates compared to other donors. (14)

We could not determine any association of gender with adverse reactions because virtually all blood donors were male. Female blood donors constituted 30% of blood donations reported from Italy. (21) However, the situation in Pakistan is even more alarming, where the prevalence was < 1% as reported in prior studies. (6,22) The reasons for the lack of blood donation include insufficient knowledge, lack of education, misconceptions, and false perceptions about blood donation. This is a limitation of our study that hinders the generalization of the results.

However, an Urdu-speaking linguistic background and undergraduate educational status were determined as significantly strong predictors of delayed syncope and fainting, respectively, in our study. In the literature, we did not find other studies that mentioned linguistic background or educational status as a risk factor associated with adverse events. Further studies are needed to validate this finding.

In our cohort, the second and third most common types of adverse events were nausea and fainting. In one European study, fainting was reported as an adverse event in 20.5% of blood donors. (23) The authors of the study concluded that the stressing experience of phlebotomy was the reason for the higher frequency of reactions. There are plausible explanations for this high prevalence compared to our study: the divergence in donor's demographics, perceptions, awareness, and understanding.

Needle injuries can damage vasculature, may result in bruises, hematoma, arterial puncture, arteriovenous fistula, or pseudoaneurysm. Needle injuries were encountered minimally (2%), which was in agreement with a prior study from Bangladesh. (10) However, Newman et al, (24) had disclosed very high frequency of bruises in 15.1% of donors while Agnihotri et al, (8) determined hematoma as an adverse event in 35% of all reactions. Underlying etiology seems to be the faulty technique, untrained phlebotomists and failure to select an appropriate vein. (8) Needle-associated nerve injuries occur in one of every 6300 donations. (24) Nerve injury was not observed in our donors. Additionally, serious fatal adverse reactions such as arterial prick, cardiac arrest, and seizures were not seen.

The prevalence of adverse donor reactions in our study was not high. However, to further minimize these adverse events and sustain the donor pool, we would suggest a number of strategies. These include lessening the donor-to-phlebotomist ratio, more pre-donation counseling, not allowing donors who have fasted before donating to donate, giving more individual concentration to each donor, keeping donors supine for longer, offering fluids before starting phlebotomy, and training blood donors about applying muscle tension exercises. (25)

CONCLUSION

The prevalence of adverse reactions in allogeneic blood donors in the Pakistani population appears low. VVR is the predominant adverse event. Donation-related adverse reaction is a multifactorial process principally determined by young age, low weight, ethnic background, and undergraduate educational status. Our study strengthens the fact that donation process is a safe maneuver, which could be made further event-free by designing protective practices in the identified predisposed groups.

ARTICLE INFO

Article history:

Received: 28 May 2015

Accepted: 19 October 2015

Online:

DOI 10.5001/omj.2016.24

Disclosure

The authors declared no conflicts of interest. No funding was received for this study.

Acknowledgements

The authors are grateful to the donors who have participated in this study. We thank the staff of the Blood Bank particularly Mr. Asif Hammed for his support.

REFERENCES

(1.) Eder AF, Notari EP IV, Dodd RY. Do reactions after whole blood donation predict syncope on return donation? Transfusion 2012 Dec; 52(12):2570-2576.

(2.) Custer B, Rios JA, Schlumpf K, Kakaiya RM, Gottschall JL, Wright DJ; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Adverse reactions and other factors that impact subsequent blood donation visits. Transfusion 2012 Jan; 52(1):118-126.

(3.) Assarian Z, Abed Haghighi B, Javadi I, Fotouhi A, Seighali F, Akbari N. Risk factors for vasovagal reactions during blood donation. Sci J Iran Blood Transfus Organ. 2011;7(4):221-226.

(4.) Zeiler T, Lander-Kox J, Eichler H, Alt T, Bux J. The safety of blood donation by elderly blood donors. Vox Sang 2011 Nov; 101(4):313-319.

(5.) Newman BH, Pichette S, Pichette D, Dzaka E. Adverse effects in blood donors after whole-blood donation: a study of 1000 blood donors interviewed 3 weeks after whole-blood donation. Transfusion 2003 May; 43(5):598-603.

(6.) Rohra DK, Juriasinghani V, Rai K, Azam SI. Prevalence of immediate vasovagal reaction in blood donors visiting two blood banks of Karachi. Transfus Me d 2010 Jun; 20(3):129-133.

(7.) Patidar GK, Sharma RR, Marwaha N. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India. Transfus Apher Sci 2013 Oct; 49(2):244-248.

(8.) Agnihotri N, Marwaha N, Sharma RR. Analysis of adverse events and predisposing factors in voluntary and replacement whole blood donors: A study from north India. Asian J Transfus Sci 2012 Jul; 6(2):155-160.

(9.) Abhishekh B, Mayadevi S, Usha KC. Adverse reactions to blood donation. Innovative Journal of Medical and Health Science. 2013; 3(4):158-160.

(10.) Mahbub-ul-Alam M, Hyder MS, Khan MB, Islam MA. Adverse donor reaction during and immediately after Venesection. The Journal of Teachers Association RMC. Rajshahi 2007; 20(1):39-47.

(11.) Crocco A, D'Elia D. Adverse reactions during voluntary donation of blood and/or blood components. A statistical-epidemiological study. Blood Transfus 2007 Jul; 5(3):143152.

(12.) Inaba S, Takanashi M, Matsuzaki K, Ono Y, Nakajima K, Shibata R, et al. Analysis of a questionnaire on adverse reactions to blood donation in Japan. Transfus Apher Sci 2013 Feb; 48(1):21-34.

(13.) Philip J, Sarkar RS, Jain N. A single-centre study of vasovagal reaction in blood donors: Influence of age, sex, donation status, weight, total blood volume and volume of blood collected. Asian J Transfus Sci 2014 Jan; 8(1):43-46.

(14.) Trouern-Trend JJ, Cable RG, Badon SJ, Newman BH, Popovsky MA. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion 1999 Mar; 39(3):316-320.

(15.) Veldhuizen I, Atsma F, van Dongen A, de Kort W. Adverse reactions, psychological factors, and their effect on donor retention in men and women. Transfusion 2012 Sep; 52(9):1871-1879.

(16.) Eder AF, Hillyer CD, Dy BA, Notari EP IV, Benjamin RJ. Adverse reactions to allogeneic whole blood donation by 16and 17-year-olds. JAMA 2008 May; 299(19):2279-2286.

(17.) Pathak C, Pujani M, Pahuja S, Jain M. Adverse reactions in whole blood donors: an Indian scenario. Blood Transfus 2011 Jan; 9(1):46-49.

(18.) France C. Baroreflex sensitivity during noxious stimulation in vasovagal reactors to blood donation. Int J Psychophysiol 1995 Feb; 19(1):13-22.

(19.) Kasprisin DO, Glynn SH, Taylor F, Miller KA. Moderate and severe reactions in blood donors. Transfusion 1992 Jan; 32(1):23-26.

(20.) Newman BH. Vasovagal reaction rates and body weight: findings in high- and low-risk populations. Transfusion 2003 Aug; 43(8):1084-1088.

(21.) Bani M, Giussani B. Gender differences in giving blood: a review of the literature. Blood Transfus 2010 Oct; 8(4):278-287.

(22.) Irfan SM, Uddin J, Zaheer HA, Sultan S, Baig A. Trends in transfusion transmitted infections among replacement blood donors in karachi, pakistan. Turk J Haematol 2013 Jun; 30(2):163-167.

(23.) Zervou EK, Ziciadis K, Karabini F, Xanthi E, Chrisostomou E, Tzolou A. Vasovagal reactions in blood donors during or immediately after blood donation. Transfus Med 2005 Oct; 15(5):389-394.

(24.) Newman BH, Waxman DA. Blood donation-related neurologic needle injury: evaluation of 2 years' worth of data from a large blood center. Tran sfusion 1996 Mar; 36(3):213-215.

(25.) Ditto B, Wilkins JA, France CR, Lavoie P, Adler PS. On-site training in applied muscle tension to reduce vasovagal reactions to blood donation. J Behav Med 2003 Feb; 26(1):53-65.

Sadia Sultan [1] *, Mohammad Amjad Baig [1], Syed Mohammed Irfan [1], Syed Ijlal Ahmed [2] and Syeda Faiza Hasan [2]

[1] Department of Hematology and Blood Bank, Liaquat National Hospital and Medical College, Karachi, Pakistan [2] Liaquat National Medical College, Karachi, Pakistan

* Corresponding author: [mail]sadia.sultan@lnh.edu.pk
Table 1: Distribution of adverse donor reactions (n
= 537).

Adverse                 Number of       Percentage
reactions            positive adverse   of positive
                        reactions        reactions

Vasovagal reaction         429             79.9
Weakness                   429             79.9
Sweating                   404             75.2
Low pulse                  393             73.2
Pallor                     330             61.5
Dizziness                  225             41.9
Nausea                     133             24.8
Fainting                    63             11.8
Hyperventilation            35              6.5
Delayed syncope             9               1.7
Hematoma                    9               1.7

Table 2: Correlation of adverse reactions with age, weight,
education, language, and gender.

Parameters               Vasovagal           Fainting
                          reaction

                     n = 429   p-value   n = 63   p-value

Age (years)
  < 30                 349      0.000      45      0.340
  [greater than or     80                  18
    equal to] 30
Weight (kg)
  < 70                 322      0.004      45      0.190
  70-90                98                  18
  > 90                  9                  0
Education
  Undergraduate        170      0.101      45      0.000
  Graduate             250                 18
  Postgraduate          9                  0
Language
  Urdu                 268      0.410              0.001
  Non-Urdu             161                 36
Gender
  Male                 429       --        63       --
  Female                0                  0

Parameters                  Nausea       Hyperventilation

                     n = 133   p-value   n = 35   p-value

Age (years)
  < 30                 89       0.003      17      0.000
  [greater than or     44                  18
    equal to] 30
Weight (kg)
  < 70                 107      0.017      17      0.000
  70-90                26                  9
  > 90                  0                  9
Education
  Undergraduate        62       0.021      17      0.351
  Graduate             71                  18
  Postgraduate          0                  0
Language
  Urdu                 71       0.031      18      0.210
  Non-Urdu             62                  17
Gender
  Male                 133       --        35       --
  Female                0                  0

Parameters               Delayed            Hematoma
                         syncope

                     n = 9   p-value   n = 9   p-value

Age (years)
  < 30                 9      0.121      0      0.000
  [greater than or     0                 9
    equal to] 30
Weight (kg)
  < 70                 9      0.190      9      0.191
  70-90                0                 0
  > 90                 0                 0
Education
  Undergraduate        0      0.040      9      0.001
  Graduate             9                 0
  Postgraduate         0                 0
Language
  Urdu                 9      0.011      0      0.000
  Non-Urdu             0                 9
Gender
  Male                 9       --        9       --
  Female               0                 0
COPYRIGHT 2016 Oman Medical Specialty Board
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:ORIGINAL ARTICLE
Author:Sultan, Sadia; Baig, Mohammad Amjad; Irfan, Syed Mohammed; Ahmed, Syed Ijlal; Hasan, Syeda Faiza
Publication:Oman Medical Journal
Article Type:Clinical report
Geographic Code:9PAKI
Date:Mar 1, 2016
Words:3092
Previous Article:The prevalence and the determinants of musculoskeletal diseases in Emiratis attending primary health care clinics in Dubai.
Next Article:Breast cancer knowledge and breast self-examination practices among female university students in Kampala, Uganda: a descriptive study.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters